Johnson & Johnson JNJ

$270.47 +3.33 (1.25%)

Valuation

Market cap
656,473,472,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
P/E (trailing)
26.17
P/E (forward)
25.07
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
11,915,675
Avg volume
7,466,768
Day's range
$269.47 – $272.50
Shares out
2,407,310,000
Stochastic %K
10%
Beta
0.22
Analysts
Moderate Buy
Price target
$283.64

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

frb1985 Nov 20, 7:42 PM
$JNJ love my lucky charm. U post and it’s up $4 😆
0 replies
DERICKTRADE Nov 20, 7:35 PM
🟢 $JNJ 11/27/26 $282.5 CALL @ $0.53 Swing Setup 📈 Manage Your Risk (MYR). Wait for confirmation and follow the entry plan.
0 replies
Prime_Pips Nov 20, 7:29 PM
$JNJ 27 NOV 26 $282.5 CALL Entry: $0.53 🚨 ATH breakout in play. Bullish outside bar confirmation. Watching continuation. Risk managed.
0 replies
topstockalerts Nov 20, 6:38 PM
Investors hid out in defensive areas of the market, with retailers such as Walmart and Costco as well as others like Johnson & Johnson and Procter & Gamble seeing gains. Walmart gained almost 3%, while Costco added nearly 2%. Johnson & Johnson and Procter & Gamble each rose more than 1%. “The stock market is going through an AI repricing, reflecting an environment of slowing data center buildouts, reduced funding sources for AI-related projects and a slower trajectory of technology-related earnings growth,” said Richard Saperstein, chief investment officer at Treasury Partners. For the week, the Dow has fallen 6%, putting it on pace for its worst weekly performance since April 2025 in the wake of President Donald Trump’s sweeping tariffs announcement. The S&P 500 has decreased 7%, while the Nasdaq is down about 8%, with both also headed for their largest one-week pullbacks in more than a year. $WMT $COST $JNJ
0 replies
tock_strader Nov 20, 5:25 PM
$GIS $QQQ $CAG $JNJ $DIA there's still time to get these defensive high dividend stocks for cheap
0 replies
HydrogenH2 Nov 20, 5:08 PM
$JNJ $PG $KO $SPY Cash is probably a better option for now !! i'm 75% cash...and most defensive stocks are also topping... Recession is problably @ corner ... and Inflation persist... next "STAGFLATION" and lots of job loss are coming from AI... and US debt is going to be @ $120% of US GDP by 2036... !! Enjoy Nero & his bunch of clowns !!
0 replies
UncleSteven Nov 20, 4:32 PM
IMO, it's too late to swap AI and tech into $JNJ $PG $KO whatever defensive stocks. You're just locking in your losses. You should be moving in the other direction. Just my opinion. Don't do what I say. I don't know anything. I'm down nearly one entry-level Ferrari from my ATH. Listen to Tom Lee or Nancy.
0 replies
macrossluvsrobotech Nov 20, 4:14 PM
$BIB $JNJ $LXRX $NVO $UHS And into Q 1 2027 no less... lol... 🤦‍♂️ Just wow.
0 replies